XTLB

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)

About XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Details

Daily high
$1.21
Daily low
$1.21
Price at open
$1.24
52 Week High
$4.99
52 Week Low
$1.00
Market cap
16.1M
Dividend yield
0.00%
Volume
615
Avg. volume
7,567
P/E ratio
-9.41

XTL Biopharmaceuticals Ltd. American Depositary Shares News

Details

Daily high
$1.21
Daily low
$1.21
Price at open
$1.24
52 Week High
$4.99
52 Week Low
$1.00
Market cap
16.1M
Dividend yield
0.00%
Volume
615
Avg. volume
7,567
P/E ratio
-9.41